Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review
- 14 September 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 26 (1) , 168-175
Abstract
Background: On 31 December 2013, the US Preventive Services Task Force rated low-dose computed tomography (LDCT) for lung cancer screening as level ‘B’ recommendation. Yet, lung cancer screening implementation remains controversial, particularly when considering its cost-effectiveness. The aim of this work is to investigate the cost-effectiveness of LDCT screening program for lung cancer by performing a systematic literature review. Methods: We reviewed the published economic evaluations of LDCT in lung cancer screening. MEDLINE, ISI Web of Science and Cochrane databases were searched for literature retrieval up to 31 March 2015. Inclusion criteria included: studies reporting an original full economic evaluation; reports presenting the outcomes as Quality-Adjusted Life Years (QALYs) gained or as Life Years Gained. Results: Nine economic evaluations met the inclusion criteria. All the cost-effectiveness analyses included high risk populations for lung cancer and compared the use of annual LDCT screening with no screening. Seven studies reported an incremental cost-effectiveness ratio below the threshold of US$ 100 000 per QALY gained. Conclusions: Cost-effectiveness of LDCT screening for lung cancer is an highly debatable issue. Currently available economic evaluations suggest the cost-effectiveness of LDCT for lung cancer screening compared with no screening and indicate that the implementation of LDCT should be considered when planning a national lung cancer screening program. Additional economic evaluations, especially from a societal perspective and in an EU-setting, are needed.Keywords
This publication has 24 references indexed in Scilit:
- Results of Initial Low-Dose Computed Tomographic Screening for Lung CancerNew England Journal of Medicine, 2013
- Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial ResultsPLOS ONE, 2013
- Cost-Effectiveness of Computed Tomography Screening for Lung Cancer in the United StatesJournal of Thoracic Oncology, 2011
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid SynoviumPLOS Medicine, 2009
- The Pittsburgh Lung Screening Study (PLuSS): Outcomes within 3 Years of a First Computed Tomography ScanAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year resultsThe Lancet, 2003
- Lung Cancer Screening with CT: Mayo Clinic ExperienceRadiology, 2003
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999